AI-designed mRNA vaccines for diseases that don't exist yet: the new business
AI is designing mRNA vaccines against diseases that don't exist yet. The pharmaceutical business reinvents itself: selling prevention of what might happen. Economic analysis.
English · Original discussion in Spanish · Published
AI-designed mRNA vaccines: pandemic insurance sold before the fire starts
The same technology that accelerated the ELbichito vaccines is now preparing for a qualitative leap: using artificial intelligence to design preventive immunizations against diseases that have not yet appeared. This is not science fiction; it is the horizon set by the latest developments in mRNA combined with generative AI models. The concept is as simple as it is unsettling: if AI can predict which pathogens might have pandemic potential, it can also design antigens for them and start injecting before they even exist.
The business is airtight. Pharmaceutical companies, which during the pandemic proved their ability to shape the government agenda, find here a natural extension of their recurring revenue model. No longer is a vaccine given against a real disease, but against what "might happen." The same logic as selling umbrellas in the middle of a drought: you collect the premium on an insurance policy against something that may never arrive, but which justifies the annual injection. And meanwhile, the underlying problem —unsustainable pensions, strained public healthcare— goes unsolved, but the needle keeps going in.
The economic calculations underlying this shift are devastating. An annual vaccination cycle for the entire population against a range of potential threats multiplies the industry's revenue by a factor that no official analysis has made public. With AI generating antigens for mutations it could itself design, the circle closes: the bicho is created, predicted, and vaccinated against. Whoever controls the AI controls the entire cycle.
Related discussions in the forum
The same technology that accelerated the ELbichito vaccines is now preparing for a qualitative leap: using artificial intelligence to design preventive immunizations against diseases that have not yet appeared. This is not science fiction; it is the horizon set by the latest developments in mRNA combined with generative AI models. The concept is as simple as it is unsettling: if AI can predict which pathogens might have pandemic potential, it can also design antigens for them and start injecting before they even exist.
The business is airtight. Pharmaceutical companies, which during the pandemic proved their ability to shape the government agenda, find here a natural extension of their recurring revenue model. No longer is a vaccine given against a real disease, but against what "might happen." The same logic as selling umbrellas in the middle of a drought: you collect the premium on an insurance policy against something that may never arrive, but which justifies the annual injection. And meanwhile, the underlying problem —unsustainable pensions, strained public healthcare— goes unsolved, but the needle keeps going in.
The economic calculations underlying this shift are devastating. An annual vaccination cycle for the entire population against a range of potential threats multiplies the industry's revenue by a factor that no official analysis has made public. With AI generating antigens for mutations it could itself design, the circle closes: the bicho is created, predicted, and vaccinated against. Whoever controls the AI controls the entire cycle.
Related discussions in the forum
- MARLASKON EXPLODING LIVE · 176 replies
- LEIREAZO: a certain Viera (PSOE Seville) killed his vvife and they covered it up. A KIDNAPPING emerges · 136 replies
- Where does the crap shat by 3.5 million Madrid backsides end up, doesn't it disgust you? · 107 replies
- The Valencian 'Top Gun' and her partner Boyer arrested for abusing their adopted children. · 205 replies
Also available in: Deutsch
Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication. Read the full discussion (11 replies).
More summaries
-
Cancer doesn't exist: the theory challenging oncology and its numbers
A JAMA study dismantles the theory that cancer is an immune response. The debate over whether it is a pharmaceutical business remains open.
-
Cancer mortality: debunking the 97% myth and the $291 billion industry
2024 data shows 20.6 million cases and 9.8 million deaths. The 97% figure is false, but spontaneous remission exists within a massive pharmaceutical market.
-
Pfizer eclipse glasses: when branding replaces eye safety certification
Stacking three pairs of eclipse glasses offers no protection at all, and the Pfizer name certifies nothing: this is how marketing sneaks into eye safety.
-
Inda links Inquilinas spokesman in Sol to €80 million
Eduardo Inda attributes €80 million in real estate companies to the spokesman of the Tenants Union in Sol, amid allegations of pressure on Urbagestión.
-
Spain is no longer 'third world'... it's far worse, viral post claims
A viral message claims Spain is the country with the most train accident deaths in two years, ahead of Zimbabwe or India. No official data backs it up.
-
Political row in Spain over turning every tragedy into campaign ammo
Forum users slam PP, PSOE and Vox for exploiting tragedies, but the outrage quickly turns back on whoever voices it.